{
  "id": "025f3db82f4567cb",
  "title": "STAT+: Pharmalittle: We\u2019re reading about Europe\u2019s pharma supply chain, stopping GLP-1 drugs, and more",
  "description": "Many patients using GLP-1 drugs like Wegovy may not regain lost weight quickly when they stop treatment, an analysis of real-world data shows",
  "content": "Many patients using GLP-1 drugs like Wegovy may not regain lost weight quickly when they stop treatment, an analysis of real-world data shows",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2026/01/22/europe-insulin-novo-weight-cvs-pharmacies/?utm_campaign=rss",
  "published_at": "2026-01-22T14:26:57+00:00",
  "fetched_at": "2026-01-23T00:24:24.269073+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug",
    "ai"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Pharmalittle: We\u2019re reading about Europe\u2019s pharma supply chain, stopping GLP-1 drugs, and more",
    "description": "Many patients using GLP-1 drugs like Wegovy may not regain lost weight quickly when they stop treatment, an analysis of real-world data shows",
    "url": "https://www.statnews.com/pharmalot/2026/01/22/europe-insulin-novo-weight-cvs-pharmacies/?utm_campaign=rss",
    "published": "2026-01-22T14:26:57+00:00",
    "source": "STAT"
  }
}